Chester County News and Community Website
NEWTOWN, PA — Traws Pharma, Inc. announced its second quarter 2024 financial results and highlighted key developments following its merger with Trawsfynydd Therapeutics. The merger, completed in April, included a …
Traws Pharma Reports Q2 Financials and Merger with Trawsfynydd Therapeutics Read More NEWTOWN, PA — Traws Pharma, Inc. has unveiled encouraging preclinical results for its COVID-19 drug, ratutrelvir, at the International Conference on Antiviral Research (ICAR2024) in Gold Coast, Australia. Ratutrelvir, also …
Traws Pharma Showcases Promising COVID-19 Drug at ICAR Conference Read More NEWTOWN, PA — Traws Pharma, Inc. (Nasdaq: TRAW) reported its financial results for the first quarter of 2024 this week, alongside an update on its business developments that signal a …
Traws Pharma Announces First Quarter Financial Results and Progress in Respiratory and Oncology Programs Read More
NEWTOWN, PA — Traws Pharma, Inc. announced this week the completion of dosing in the first cohort of a groundbreaking Phase 1 study on travatrelvir (TRX01), an innovative oral protease …
Traws Pharma Advances COVID-19 Treatment into First Human Trials Read More